Member Info for lunar3890

Kdonkey they didn't hire a company they hired a singular person (board member) whose name escapes me, but iirc he has previously a couple of companies through acquisition, jump back on the RNS it was probably circa 9 months ago

I stupidly averaged down for the 4th time to 19p, I should have put it elsewhere, what's your average at now?

I think the imbalance is due to the nature of this product, when people buy something especially that is a little taboo, they wont go on to say they had a wonderful night and hard for hours, they'll buy it again and again without posting a review, why would they? The reason its super negative is because the others have spent £25 on what they deem has done nothing and therefore want to complain. I mean there is 319 negative reviews on boots 2* and below, how many do you think boots have sold? I imagine and hope its thousands. I do agree though it is very annoying that potentially a great product looks poor because of the 30% it doesn't work for. lets hope the rest of the paying public will try it regardless.

You couldnt make this up.....

FUM are now largely de-risked having signed a great partner in HALEON, taking the company into the largest ED market in the world and current sales are great. How is this stock still sitting in the low 50's?

you cannot forget that ***

I think this will keep yo-yo’ing until cooper either complete their European product launch and or FDA approval has been granted, anyone who sells now is clearly in it for the short term, and fair play, but there is huge upside to this price at present. The ED market is currently worth circa $3.6bn. I think after the EU and South American roll out + FDA approval, this will be easily worth 1.20-1.40.

The product is still not showing on Coopers home page https://www.cooperconsumerhealth.eu/our-brands/

We have approval though, just not in the states, which granted is the biggest market.. I am surprised they are selling without any launch in Europe. I would expect the marketing to be on posters in tube stations, tube trains, rest rooms at motorway service stations etc, etc. Does anybody know exactly what the deal with cooper said regarding marketing? Will they complete all marketing or a %, is it linked to FDA, etc?

me too

My research previously of FDA Timescales was not encouraging, most applications took longer that 9 months till decision, The focus for 2023 should be on the European soft launch that cooper are in the throws of now. Early uptake and sales through Cooper should put us into the £1 territory

IMO for £2 to be breached there would need to be some sizeable sales and US approval and partner signed, I think 90p - £1 in the next 6 months is more realistic.

Good find on the webinar, they most likely may be having two separate launches for UK and EU.

I hope the wider market picks up on this launch soon, the volume has been super low over the last week, I was hoping cooper health would start marketing campaign prior to launch.

Its a real surprise to see people selling when launch is so close. sales is sales money in the bank will absolutely lift the share price, I firmly believe people will try this product.

81 is correct, their goal is a 150 days

I don't understand the sells today? its not like we are up 20%+ and people are consolidating.

Jay -45% that's good mines closer to -80% I tend not to look at it, its that depressing.

I am really surprised that this isn't blue today, I think the BOD have done exactly what they said they would do, the project as a whole is de-risked, and also gearing up to receive orders. Firm hold here.

Everyone has FOMO, hopefully the next few weeks sets a new resistance at 50+. There was always going to be some selling following the recent RNS, I think that has concluded now and hopefully we should see a steady ship and maybe gradual rise over the next few months.

guy thanks for making the day of a long suffering share holder